Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes

Wei Zou(Nanchang University), J. Víctor García(University of North Carolina at Chapel Hill), Paul W. Denton(University of Nebraska at Omaha), John F. Krisko(University of North Carolina at Chapel Hill), Tomonori Nochi(University of North Carolina at Chapel Hill), John L. Foster(The University of Texas Southwestern Medical Center), Richard L Watkins(University of North Carolina at Chapel Hill)
Retrovirology
May 28, 2012
10.1186/1742-4690-9-44
Cited by 66

Related Papers

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367
HIV-1 Nef: at the crossroads
|Retrovirology|2008|209
Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice
|PLoS ONE|2010|166
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
|Clinical Infectious Diseases|2017|146
One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
|Journal of Virology|2011|137